https://clinicaltrials.gov/ct2/show/NCT03528551?type=Intr&cond=hemophilia&lupd_s=03%2F08%2F2019&lupd_d=14
Conditions : Congenital Bleeding Disorder; Haemophilia A
Intervention : Drug: Turoctocog alfa pegol
Sponsor : Novo Nordisk A/S
Enrolling by invitation
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
NCT03528551
Fri, 18 May 2018 12:00:00 EDT
Last Update Posted: 03/22/19 09:19AM
